louisiana glp-1 ileus class action The RA Legal Timeline: How Serious Side Effects Led to Multidistrict Litigation First lawsuit for weight loss,

Discover strategies to manage this side effect from weight loss treatments.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), widely used for metabolic disorders, have emerged as promising candidates for a range of neuropsychiatric conditions due to their broad neurobiological effects

Shop doctor-formulated transdermal patches for weight loss, NAD+ energy, GLP-1 support, and menopause relief

Clinical trials testing GLP-1 receptor agonists in patients with AD or PD have been conducted and have shown first successes, serving as proof of concept that activating GLP-1 receptor is a sensible strategy to treat AD/PD

With key GLP-1 drug patents expected to expire around March 2026, Indian pharmaceutical companies are preparing to launch lower-cost alternatives in one of the fastest-growing therapeutic markets